Oncology Letters · 2014 · 38 citations · 9 references
Life SciencesHematologyImmunologyCancer ImmunologyClinical ImmunologyTumor ProgressionHuman Leukocyte Antigen SystemLymphocyte DevelopmentLymphoid NeoplasmsMyeloid-derived Suppressor CellsT Cell DifferentiationMyeloid-derived Suppressor Cell Clinical SignificanceMyeloid-derived Suppressor Cell FunctionMyeloid-derived Suppressor Cell MarkersMyeloid-derived Suppressor Cell SubsetsMyeloid-derived Suppressor Cell-mediated SuppressionPrognostic Factors AnalysisT Cell-mediated Immune ResponseT-cell Mediated Immune Response
Currently, no prognostic factors exist for determining the host immune status of chronic lymphocytic leukemia (CLL) patients. Therefore, the present report analyzed cluster of differentiation 14 (CD14)+ human leukocyte antigen (HLA)‑DRlow/‑ myeloid‑derived suppressor cells (MDSC) from 49 CLL patients and demonstrated that these cells were significantly expanded in all CLL patients when compared with monoclonal B cell lymphocytosis patients and healthy volunteers. Furthermore, upregulation of CD14+HLA‑DRlow/‑ MDSCs was correlated with CLL tumor progression and a poor prognosis for CLL patients, and CD14+HLA‑DRlow/‑ MDSCs were significantly correlated with the presence of CD4+ T and CD5+CD19+ cells in CLL patients, which could significantly inhibit the CD4+ T‑cell immune response, contributing to CLL cell progression in CLL patients.
9
Michael Hallek, Bruce D. Cheson, Daniel Catovsky et al. · Blood · 2008 · 3.2K citations · Full text
Medicine, Hematology, Oncology +14
Rajendra N. Damle, Tarun Wasil, Franco Fais et al. · Blood · 1999 · 2.6K citations
Medicine, Hematology, Oncology +12
Paola Filipazzi, Roberta Valenti, Veronica Huber et al. · Journal of Clinical Oncology · 2007 · 641 citations
Life Sciences, Immunology, Oncology +17
ZAP-70 expression and prognosis in chronic lymphocytic leukaemia
Jenny Orchard, Rachel Ibbotson, Zadie Davis et al. · The Lancet · 2004 · 558 citations
Medicine, Hematology, Immunology +12